Post Market Clinical Follow-Up of Acetabular Titan-Augment Structan®

Post Market Clinical Follow-Up of Acetabular Titan-Augment Structan®

Implant Survival as well as clinical and radiological Follow-Up of acetabular Titan-Augment Structan®

Inclusion Criteria:

• Minimum age 18 years
• Indication for cementless hip arthroplasty with acetabular defects that need Allograft or titanium augment
• Patient consent for study participation
• Physical and mental willingness to participate in the follow-ups

Exclusion Criteria:

• Patient not available for follow-up
• Increased anesthetics risks for the patient according to the "American Society of Anesthesiology": ASA IV
• Tumor
• Alcohol- or Drug abuse
• Permanent cortisone therapy
• Clinically relevant infection
• (Planned) pregnancy